CMBC Capital Holdings (FRA:4C30) Research & Development: €0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:4C30 CMBC Capital Holdings Ltd FRA:4C30
43 GF Score
Price €0.50
GF Value €0.08
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is CMBC Capital Holdings Research & Development?

CMBC Capital Holdings FRA:4C30 -0.99% 43 Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:4C30 with a GF Score™ of 43/100 and a GF Value™ of €0.08 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CMBC Capital Holdings's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

CMBC Capital Holdings  (FRA:4C30) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CMBC Capital Holdings Research & Development Related Terms

CMBC Capital Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for CMBC Capital Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CMBC Capital Holdings Research & Development Chart

CMBC Capital Holdings Annual Data
Trend Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CMBC Capital Holdings Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:4C30
43GF Score
CMBC Capital Holdings Ltd FRA:4C30
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CMBC Capital Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
CMBC Capital Holdings (FRA:4C30) has a Research & Development of €0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on CMBC Capital Holdings and its competitors.
Is CMBC Capital Holdings' Research & Development too high?
CMBC Capital Holdings' current Research & Development is €0.00 Mil. Overall, CMBC Capital Holdings has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CMBC Capital Holdings' Research & Development compare to MS and GS?
CMBC Capital Holdings' Research & Development of €0.00 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Capital Markets company?
A good Research & Development depends on the Capital Markets industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CMBC Capital Holdings and its competitors. CMBC Capital Holdings's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CMBC Capital Holdings stock overvalued right now?
Based on GuruFocus' analysis, CMBC Capital Holdings (FRA:4C30) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.08, compared to a current price of €0.50 — trading 525% above its estimated fair value. The current Research & Development is €0.00 Mil. CMBC Capital Holdings' overall GF Score™ is 43/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CMBC Capital Holdings (FRA:4C30), the current Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CMBC Capital Holdings (FRA:4C30) Overvalued in 2026?

Based on GuruFocus' analysis, CMBC Capital Holdings stock appears to be overvalued. The current stock price of €0.50 is trading 525% above its estimated GF Value™ of €0.08. GuruFocus considers CMBC Capital Holdings to be Significantly Overvalued.

Key valuation signals for FRA:4C30:

  • Research & Development: €0.00 Mil
  • GF Value™: €0.08 vs. price of €0.50 (525% above fair value)
  • GF Score™: 43/100 with 9 warning signs

No single metric tells the full story. See the FRA:4C30 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CMBC Capital Holdings Business Description

Other Exchanges 01141:Hong Kong
Address 8 Connaught Place, 34th Floor, One Exchange Square, Central, Hong Kong, HKG
CMBC Capital Holdings Ltd engages in the provision of loan financing services. It operates through the following segments: Securities, Fixed-income direct investment, Other Investment and Financing, Asset Management, Corporate Finance and Advisory, and others. The company's operations are carried out in Hong Kong.
43GF Score

Get the complete analysis for FRA:4C30

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.50
Price
€0.08
GF Value